Healthpeak Properties, Inc. (NYSE:DOC) Shares Sold by Kingswood Wealth Advisors LLC

Kingswood Wealth Advisors LLC decreased its holdings in Healthpeak Properties, Inc. (NYSE:DOC) by 50.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 17,773 shares of the real estate investment trust’s stock after selling 18,355 shares during the quarter. Kingswood Wealth Advisors LLC’s holdings in Healthpeak Properties were worth $360,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. JPMorgan Chase & Co. lifted its position in shares of Healthpeak Properties by 23.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 21,561,640 shares of the real estate investment trust’s stock valued at $493,115,000 after buying an additional 4,056,931 shares in the last quarter. Thrivent Financial for Lutherans purchased a new position in Healthpeak Properties during the third quarter valued at $1,880,000. Swedbank AB acquired a new stake in shares of Healthpeak Properties in the third quarter valued at about $1,832,000. Pathstone Holdings LLC purchased a new stake in shares of Healthpeak Properties during the third quarter worth about $1,968,000. Finally, Associated Banc Corp acquired a new position in shares of Healthpeak Properties during the 3rd quarter worth about $10,559,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

Analyst Ratings Changes

Several analysts recently commented on the company. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and boosted their price target for the stock from $20.00 to $28.00 in a research report on Monday, October 21st. Robert W. Baird increased their target price on shares of Healthpeak Properties from $24.00 to $25.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Mizuho cut their price objective on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a report on Thursday, December 5th. Finally, Wells Fargo & Company lowered their target price on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 10th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, ten have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $24.15.

Healthpeak Properties Stock Performance

NYSE DOC opened at $20.66 on Friday. The company has a market cap of $14.45 billion, a P/E ratio of 43.96, a P/E/G ratio of 2.18 and a beta of 1.14. Healthpeak Properties, Inc. has a 1-year low of $16.01 and a 1-year high of $23.26. The company has a debt-to-equity ratio of 0.93, a current ratio of 1.31 and a quick ratio of 1.31. The stock has a 50-day moving average of $20.75 and a two-hundred day moving average of $21.55.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.